Predicted to enable protein tyrosine kinase binding activity. Predicted to be involved in several processes, including positive regulation of cytokine production; response to bacterium; and signal transduction. Predicted to be located in apical plasma membrane and microvillus membrane. Predicted to be active in cell surface and plasma membrane. Orthologous to human CEACAM20 (CEA cell adhesion molecule 20); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 3-chloropropane-1,2-diol; acetamide.
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEACAM20 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEACAM20 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEACAM20 mRNA
Doxorubicin promotes the reaction [thymoquinone results in decreased expression of CEACAM20 protein] and thymoquinone promotes the reaction [Doxorubicin results in decreased expression of CEACAM20 protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEACAM20 mRNA
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEACAM20 mRNA and citral inhibits the reaction [Diethylnitrosamine results in increased expression of CEACAM20 protein]
Doxorubicin promotes the reaction [thymoquinone results in decreased expression of CEACAM20 protein] and thymoquinone promotes the reaction [Doxorubicin results in decreased expression of CEACAM20 protein]